Gutierrez CLD, Quero-Taggaoa AKH, Uy TCF, Veloso JAD. High-Risk Chronic Lymphocytic Leukemia in a Young Adult Treated With Reduced-Dosage, Fixed-Duration Ibrutinib and Venetoclax. J Med Cases [Internet]. 2026 Jan. 1 [cited 2026 Mar. 7];17(4):146-52. Available from: https://jmc.elmerpub.com/index.php/jmc/article/view/5237